Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products.

The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Specialty Pharmaceutical Products585.98100%872.42100% +32.83%
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States538.2291.8%792.5290.8% +32.09%
Europe38.596.6%61.847.1% +37.6%
All Other9.171.6%18.062.1% +49.23%
Ireland-----
Surperformance© rating of Jazz Pharmaceuticals PLC
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield - - -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Biotechnology
Advertisement
Sector Biotechnology
Trading RatingInvestor Rating
GILEAD SCIENCES, ..
AMGEN, INC.
BIOGEN IDEC INC
CELGENE CORPORATI..
CSL LIMITED
Sector Biotechnology
Company contact information
Jazz Pharmaceuticals Plc
Connaught House
One Burlington Road
4th floor
Dublin 4

Phone : +353.1.634.7800
Fax : +353.1.634.7850
Web : www.jazzpharma.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF